Comparing the incidence of postoperative nausea and vomiting in groups using intraoperative remimazolam versus not using intraoperative remimazolam
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0008812
- Lead Sponsor
- Pusan National University Yangsan Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Subjects between 20 and 80 years of age
Subjects scheduled to undergo laparoscopic surgery under general anesthesia in the central operating room of Pusan National University Hospital (Remimazolam: 40 subjects, Sevoflurane: 40 subjects)
Subjects who belong to the American Society of Anesthesiologists (ASA) Physical Status Classification (PSC) levels 1-3 Subjects who have voluntarily agreed in writing to participate in this clinical study.
ASA 4 or higher
Subjects who are allergic to remimazolam or sevoflurane.
Subjects without renal, hepatic, neuromuscular, or neurologic disease and taking medications related to them. Subjects habitually taking psychoactive drugs or with ischemic heart disease.
Excludes pregnant women.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Difference of PONV with remimazolam versus sevoflurane
- Secondary Outcome Measures
Name Time Method KQOR-15 score difference in remimazolam versus sevoflurane group